Park JW - Search Results

1

The Sweet syndrome during therapy with granulocyte colony-stimulating factor.

Park JW, Mehrotra B, Barnett BO, Baron AD, Venook AP. Park JW, et al. Ann Intern Med. 1992 Jun 15;116(12 Pt 1):996-8. doi: 10.7326/0003-4819-116-12-996. Ann Intern Med. 1992. PMID: 1375012 No abstract available.

2

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.

Kelley RK, Hwang J, Magbanua MJ, Watt L, Beumer JH, Christner SM, Baruchel S, Wu B, Fong L, Yeh BM, Moore AP, Ko AH, Korn WM, Rajpal S, Park JW, Tempero MA, Venook AP, Bergsland EK. Kelley RK, et al. Among authors: park jw. Br J Cancer. 2013 Oct 1;109(7):1725-34. doi: 10.1038/bjc.2013.553. Epub 2013 Sep 10. Br J Cancer. 2013. PMID: 24022191 Free PMC article. Clinical Trial.

3

Monoclonal antibody therapy.

Park JW, Smolen J. Park JW, et al. Adv Protein Chem. 2001;56:369-421. doi: 10.1016/s0065-3233(01)56010-6. Adv Protein Chem. 2001. PMID: 11329858 Review. No abstract available.

4

Autologous Fat Grafting as a Novel Antiestrogen Vehicle for the Treatment of Breast Cancer.

Thomas S, Chen S, Sbitany H, Kwon E, Piper M, Park J, Terranova Barberio M, Pawlowska N, Munster PN. Thomas S, et al. Plast Reconstr Surg. 2017 Sep;140(3):537-544. doi: 10.1097/PRS.0000000000003579. Plast Reconstr Surg. 2017. PMID: 28841614 Free PMC article.

5

Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.

Park J, Thomas S, Munster PN. Park J, et al. Epigenomics. 2015;7(4):641-52. doi: 10.2217/epi.15.16. Epigenomics. 2015. PMID: 26111034 Review.

6

A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors.

Tolcher AW, Bendell JC, Papadopoulos KP, Burris HA 3rd, Patnaik A, Jones SF, Rasco D, Cox DS, Durante M, Bellew KM, Park J, Le NT, Infante JR. Tolcher AW, et al. Ann Oncol. 2015 Jan;26(1):58-64. doi: 10.1093/annonc/mdu482. Epub 2014 Oct 24. Ann Oncol. 2015. PMID: 25344362 Free article. Clinical Trial.

7

Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer.

Park J, Thomas S, Zhong AY, Wolfe AR, Krings G, Terranova-Barberio M, Pawlowska N, Benet LZ, Munster PN. Park J, et al. Sci Rep. 2018 Jan 8;8(1):92. doi: 10.1038/s41598-017-18436-1. Sci Rep. 2018. PMID: 29311658 Free PMC article.

8

A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.

Thomas S, Aggarwal R, Jahan T, Ryan C, Troung T, Cripps AM, Raha P, Thurn KT, Chen S, Grabowsky JA, Park J, Hwang J, Daud A, Munster PN. Thomas S, et al. Ann Oncol. 2016 May;27(5):947-52. doi: 10.1093/annonc/mdw044. Epub 2016 Feb 21. Ann Oncol. 2016. PMID: 26903311 Free PMC article. Clinical Trial.

9

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.

Sahin U, Türeci Ö, Manikhas G, Lordick F, Rusyn A, Vynnychenko I, Dudov A, Bazin I, Bondarenko I, Melichar B, Dhaene K, Wiechen K, Huber C, Maurus D, Arozullah A, Park JW, Schuler M, Al-Batran SE. Sahin U, et al. Among authors: park jw. Ann Oncol. 2021 May;32(5):609-619. doi: 10.1016/j.annonc.2021.02.005. Epub 2021 Feb 19. Ann Oncol. 2021. PMID: 33610734 Free article. Clinical Trial.

10

ErbB receptors and Ras: upstream, downstream?

Park JW, McCormick F. Park JW, et al. Cancer J. 2001 May-Jun;7(3):178-80. Cancer J. 2001. PMID: 11419025 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,116 results

Search Page

Filters